BJTTHi001-A-2
General#
Cell Line |
|
| hPSCreg Name | BJTTHi001-A-2 |
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Last update | 6th March 2021 |
| User feedback | |
Provider |
|
| Generator | Beijing Tiantan Hospital (BJTTH) |
External Databases |
|
| BioSamples | SAMEA8359796 |
| CLO | CLO_0103206 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
Donor Information#
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
External Databases (Donor) |
|
| BioSamples | SAMEA8172002 |
Ethics#
Also have a look at the ethics information for the parental line
BJTTHi001-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation#
General |
|
|
The source cell information can be found in the parental cell line
BJTTHi001-A.
|
|
Reprogramming method |
|
| Vector type | None |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions#
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Medium |
Other medium:
Base medium: Nuwacell ncTarget hPSC Medium
Main protein source: Serum concentration: % |
Characterisation#
No characterisation data could be found for this subclone. Please open parental cell line BJTTHi001-AGenotyping#
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
|
Genetic Modification#
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.